Achieve Life Sciences, Inc. Proceeds from Issuance of Warrants
Achieve Life Sciences, Inc. (ACHV) reported Proceeds from Issuance of Warrants of $13.80 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2018-11-07
- Achieve Life Sciences, Inc. proceeds from issuance of warrants for the quarter ending 2018-09-30 was $0.00.
- Achieve Life Sciences, Inc. proceeds from issuance of warrants for fiscal 2010 was $14.34M.
| Period end | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $13.80K 10-Q · filed 2018-11-07 | ||||
| 2018-06-30 | $13.80K 10-Q · filed 2018-08-08 | |||||
| 2014-07-02 | $24.00M 10-K · filed 2017-02-23 | |||||
| 2010-12-31 | $14.34M 10-K · filed 2013-03-07 | |||||
| 2010-10-31 | $46.70M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |